Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry.


Journal

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
ISSN: 1969-6213
Titre abrégé: EuroIntervention
Pays: France
ID NLM: 101251040

Informations de publication

Date de publication:
19 Jun 2023
Historique:
pmc-release: 19 06 2024
medline: 19 6 2023
pubmed: 24 3 2023
entrez: 23 3 2023
Statut: ppublish

Résumé

Treatment of aortic stenosis in patients with small annuli is challenging and can result in prosthesis-patient mismatch (PPM). We aimed to compare the forward flow haemodynamics and clinical outcomes of contemporary transcatheter valves in patients with small annuli. The TAVI-SMALL 2 international retrospective registry included 1,378 patients with severe aortic stenosis and small annuli (annular perimeter <72 mm or area <400 mm The predischarge mean aortic gradient was lower after SAV versus IAV (7.8±3.9 vs 12.0±5.1; p<0.001) and SEV versus BEV implantation (8.0±4.1 vs 13.6±4.7; p<0.001). Severe PPM was more common with IAV and BEV when compared to SAV and SEV implantation, respectively, (8.8% vs 3.6%; p=0.007 and 8.7% vs 4.6%; p=0.041). At multivariable logistic regression weighted by IPTW, SAV protected from severe PPM regardless of its definition. More than mild PVL occurred more often with SEV versus BEV (11.6% vs 2.6%; p<0.001). In small aortic annuli, implantation of SAV and SEV was associated with a more favourable forward haemodynamic profile than after IAV and BEV implantation, respectively. More than mild PVL was more common after SEV than BEV implantation.

Sections du résumé

BACKGROUND BACKGROUND
Treatment of aortic stenosis in patients with small annuli is challenging and can result in prosthesis-patient mismatch (PPM).
AIMS OBJECTIVE
We aimed to compare the forward flow haemodynamics and clinical outcomes of contemporary transcatheter valves in patients with small annuli.
METHODS METHODS
The TAVI-SMALL 2 international retrospective registry included 1,378 patients with severe aortic stenosis and small annuli (annular perimeter <72 mm or area <400 mm
RESULTS RESULTS
The predischarge mean aortic gradient was lower after SAV versus IAV (7.8±3.9 vs 12.0±5.1; p<0.001) and SEV versus BEV implantation (8.0±4.1 vs 13.6±4.7; p<0.001). Severe PPM was more common with IAV and BEV when compared to SAV and SEV implantation, respectively, (8.8% vs 3.6%; p=0.007 and 8.7% vs 4.6%; p=0.041). At multivariable logistic regression weighted by IPTW, SAV protected from severe PPM regardless of its definition. More than mild PVL occurred more often with SEV versus BEV (11.6% vs 2.6%; p<0.001).
CONCLUSIONS CONCLUSIONS
In small aortic annuli, implantation of SAV and SEV was associated with a more favourable forward haemodynamic profile than after IAV and BEV implantation, respectively. More than mild PVL was more common after SEV than BEV implantation.

Identifiants

pubmed: 36950893
pii: EIJ-D-22-00843
doi: 10.4244/EIJ-D-22-00843
pmc: PMC10266383
pii:
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

256-266

Références

Circ Cardiovasc Interv. 2014 Oct;7(5):701-11
pubmed: 25270901
J Heart Valve Dis. 2013 May;22(3):309-16
pubmed: 24151756
JACC Cardiovasc Imaging. 2016 Aug;9(8):924-33
pubmed: 27236530
Front Cardiovasc Med. 2021 Jun 04;8:670457
pubmed: 34150868
Circulation. 2013 Jul 16;128(3):244-53
pubmed: 23748467
Circulation. 1978 Jul;58(1):20-4
pubmed: 348341
Eur J Cardiothorac Surg. 2018 Jun 1;53(6):1112-1117
pubmed: 29684154
Clin Res Cardiol. 2021 Dec;110(12):1912-1920
pubmed: 34148125
Eur Heart J. 2021 May 14;42(19):1825-1857
pubmed: 33871579
Lancet. 2019 Nov 2;394(10209):1619-1628
pubmed: 31570258
Lancet. 2020 Sep 5;396(10252):669-683
pubmed: 32593323
Am J Cardiol. 2016 Jul 1;118(1):107-12
pubmed: 27184169
JACC Cardiovasc Interv. 2019 Nov 11;12(21):2173-2182
pubmed: 31564593
Eur Heart J. 2020 May 21;41(20):1890-1899
pubmed: 32049283
JACC Cardiovasc Interv. 2021 Jun 14;14(11):1218-1228
pubmed: 34112458
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
JACC Cardiovasc Interv. 2018 Apr 23;11(8):771-780
pubmed: 29673509
EuroIntervention. 2019 Mar 20;14(16):1648-1655
pubmed: 30418159
Eur Heart J Cardiovasc Imaging. 2021 Jan 1;22(1):11-20
pubmed: 32995865
Catheter Cardiovasc Interv. 2021 May 1;97(6):E875-E886
pubmed: 32926552
Clin Res Cardiol. 2021 Dec;110(12):1957-1966
pubmed: 34387736
JACC Cardiovasc Interv. 2020 Jan 27;13(2):196-206
pubmed: 31883714
JACC Cardiovasc Interv. 2018 Dec 24;11(24):2507-2518
pubmed: 30503595
Circulation. 2020 Dec 22;142(25):2431-2442
pubmed: 33054367
Circ J. 2020 Oct 23;84(11):2015-2022
pubmed: 32999143
Am J Epidemiol. 2011 Apr 1;173(7):761-7
pubmed: 21385832
Stat Med. 2015 Dec 10;34(28):3661-79
pubmed: 26238958
Circ Cardiovasc Interv. 2017 Oct;10(10):
pubmed: 28951395
Ann Thorac Surg. 2016 Mar;101(3):872-80
pubmed: 26830222

Auteurs

Pier Pasquale Leone (PP)

Montefiore Medical Center, New York, NY, USA.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy.
Cardio Center, IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy.

Damiano Regazzoli (D)

Cardio Center, IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy.

Matteo Pagnesi (M)

Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.

Francesco Cannata (F)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy.
Cardio Center, IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy.

Antonio Mangieri (A)

Cardio Center, IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy.

Thijmen W Hokken (TW)

Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.

Giuliano Costa (G)

U.O.C. Cardiologia, Centro Alte Specialità e Trapianti, A.O.U. Policlinico "G. Rodolico-San Marco", Catania, Italy.

Marco Barbanti (M)

U.O.C. Cardiologia, Centro Alte Specialità e Trapianti, A.O.U. Policlinico "G. Rodolico-San Marco", Catania, Italy.

Rui Campante Teles (RC)

Hospital de Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Nova Medical School, CEDOC, Lisbon, Portugal.

Marianna Adamo (M)

Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.

Maurizio Taramasso (M)

HerzZentrum Hirslanden Zurich, Zurich, Switzerland and University of Zurich, Zurich, Switzerland.

Jorg Reifart (J)

DZHK (German Center for Cardiovascular Research), Partner Site RheinMain, Frankfurt am Main, Germany.

Federico De Marco (F)

Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Francesco Giannini (F)

GVM Care & Research, Maria Cecilia Hospital, Ravenna, Italy.

Faraj Kargoli (F)

Montefiore Medical Center, New York, NY, USA.

Yohei Ohno (Y)

Department of Cardiology, Tokai University Hospital, Kanagawa, Japan.

Francesco Saia (F)

Cardiology Unit, Sant'Orsola Polyclinic, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Andrea Buono (A)

Interventional Cardiology Unit, Cardiovascular Department, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.

Alfonso Ielasi (A)

Clinical and Interventional Unit, Sant'Ambrogio Cardio-Thoracic Center, Milan, Italy.

Michele Pighi (M)

Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy.

Mauro Chiarito (M)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy.
Cardio Center, IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy.

Dario Bongiovanni (D)

Cardio Center, IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy.

Ottavia Cozzi (O)

Cardio Center, IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy.

Giulio Stefanini (G)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy.
Cardio Center, IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy.

Flavio L Ribichini (FL)

Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy.

Diego Maffeo (D)

Interventional Cardiology Unit, Cardiovascular Department, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.

Giuliano Chizzola (G)

Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.

Francesco Bedogni (F)

GVM Care & Research, Maria Cecilia Hospital, Ravenna, Italy.

Won-Keun Kim (WK)

Department of Cardiology, Kerckhoff Heart Center, Bad Nauheim, Germany.

Francesco Maisano (F)

Cardio-Thoracic-Vascular Department, IRCCS Ospedale San Raffaele, Milan, Italy.Misc.

Corrado Tamburino (C)

Hospital de Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Nova Medical School, CEDOC, Lisbon, Portugal.

Nicolas M Van Mieghem (NM)

Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.

Antonio Colombo (A)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy.
Cardio Center, IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy.

Bernhard Reimers (B)

Cardio Center, IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy.

Azeem Latib (A)

Montefiore Medical Center, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH